NCT00182520View on ClinicalTrials.gov

Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Obsessive Compulsive Disorder
Interventions
DRUG

Topiramate

25 mg - 400 mg/day x 12 weeks

DRUG

placebo

25 - 400 mg/day x 12 weeks

Trial Locations (1)

L8S 1B7

MacAnxiety Research Centre, Hamilton

All Listed Sponsors
collaborator

Janssen-Ortho Inc., Canada

INDUSTRY

collaborator

Hamilton Health Sciences Corporation

OTHER

lead

McMaster University

OTHER

NCT00182520 - Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD) | Biotech Hunter | Biotech Hunter